2022-01-07
Dear partners and the public:
With the continuous development and growth
of our company, our English name has been changed from “BIORAY LABORATORIES
Inc.” to “BRL Medicine Inc.” according to the strategic adjustment. With
immediate effect, all our internal and external documents, materials, invoices
and accounts will use “BRL Medicine Inc.”, and “BIORAY LABORATORIES Inc.” will
no longer be used.
After “BRL Medicine Inc.” is launched, the
contracts signed under "BIORAY LABORATORIES Inc." will continue to be
valid and the original business relationship will remain unchanged. Please
kindly understand the inconvenience caused by the change of our English name
and we are in need of your support and cooperation.
We very much appreciate your continuous
support and love. With the mission of “leading innovation through gene editing,
developing breakthrough therapies for the benefit of all mankind”, and with an
open, sharing and win-win attitude, we will continue to work with global
innovative biopharmaceutical eco- chain companies to accelerate the
transformation and implementation of innovative drugs for the benefit of
patients with genetic diseases and malignant tumors worldwide!
Information Publicity Website: www.hongwin.cn
Respectfully yours,
BRL Medicine Inc.
January
7, 2022
